Effectiveness of Shugan Jieyu capsules for psychiatric symptoms of epilepsy: a systematic review and meta-analysis.

Authors:
Kim S; Kim Y; Cho SH.

Journal:
BMC Complement Med Ther

Publication Year: 2024

DOI:
10.1186/s12906-024-04361-0

PMCID:
PMC10825991

PMID:
38287355

Journal Information

Journal Title: BMC Complement Med Ther

Detailed journal information not available.

Publication Details

Subject Category: Integrative & Complementary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"Funding None."

Evidence found in paper:

"The protocol for this systematic review was registered in the International Prospective Register of Systematic Reviews (PROSPERO). The trial registration number is CRD 42,021,238,804. No ethical approval was necessary as this was a systematic review. The systematic review and meta-analysis reporting the effectiveness of Shugan Jieyu capsules for psychiatric symptoms of epilepsy was reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, and the PRISMA checklist was attached as Additional File ."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025